Skinbooster — Belotero Revive

OK Medical offers the Belotero Revive skinbooster — a unique injectable that combines cross-linked hyaluronic acid (20 mg/ml) with glycerol (17 mg/ml) in a single formulation. The glycerol draws and retains water within the dermal matrix, slowing HA breakdown and extending hydration beyond what standard HA injections achieve. A single treatment session provides lasting improvement in skin hydration, firmness, elasticity, and radiance, and may visibly reduce fine lines caused by dehydration. Unlike volume fillers, Belotero Revive spreads evenly through the mid-dermis without creating localised volume — it improves the quality of the skin's hydration network broadly rather than filling a specific crease. Administered by MUDr. Kim Štěpánková, this treatment is particularly well suited to sun-damaged or dehydrated skin and uneven skin tone.

Skinboosters occupy a distinct category within injectable aesthetics: they are not volume fillers (which displace tissue) or volumisers (which restructure anatomy), but rather dermal hydrators — products formulated to disperse through the dermis and improve its water-holding capacity and structural integrity. Belotero Revive by Merz is formulated as a monophasic cross-linked HA gel at 20 mg/ml, close in density to the skin's own natural HA concentration, ensuring good tissue integration without lumpiness or the 'filled' appearance that can occur with higher-density HA injected superficially. The second active ingredient, glycerol (17 mg/ml), is a humectant that draws water from surrounding tissue into the injection site; it also stabilises the HA against enzymatic degradation (hyaluronidase activity), extending the functional lifespan of the treatment. The clinical benefits observed in studies and clinical practice include: increased skin moisture content (measurable by corneometry), improved elasticity and firmness on clinical scoring, visible reduction in superficial dehydration lines, more even skin tone, and a subjective improvement in skin radiance. These effects are most pronounced in sun-damaged skin, mature skin with structural water loss, and younger skin undergoing seasonal dehydration. At OK Medical, MUDr. Štěpánková administers Belotero Revive via multiple microinjections into the mid-dermis using a fine needle. The injection pattern covers the treatment zone evenly — typically the face, with optional extension to the neck or décolletage. The product contains no lidocaine, so topical anaesthetic cream may be applied beforehand for comfort. A key clinical characteristic is the single-treatment approach: unlike traditional HA skinboosters that typically require three sessions one month apart, Belotero Revive's glycerol-HA synergy is designed to produce meaningful lasting effects from a single application — making it appropriate for patients who prefer a less frequent maintenance schedule. Post-treatment: mild redness and small injection-point marks resolve within 24 hours. Avoid sauna, pool, and intense exercise for 48 hours. Full hydration improvement develops over 7–14 days as the product integrates with surrounding tissue. Contraindications: active skin infection, HA allergy, pregnancy, and breastfeeding.